Research and Health

A total of 232 biomedical and technological research projects supported in Spain and Portugal, 50 spin-offs created, four innovation licences granted to companies and more than 19 clinical trials conducted – these are some of the achievements over ...

The CaixaImpulse call for proposals to support health innovation projects has been bringing research closer to patients for a decade. Here we highlight some of the 232 biomedical and technological research projects supported by the programme in ...

Attending to spiritual needs can have a significant impact on the well-being of people in the final stage of life. At the San Camilo palliative care unit in Tres Cantos (Madrid), several patients with advanced illnesses and their families share ...

Study with data from over 1.6 million children across 68 low and middle-income countries shows that early-life exposure to economic shocks is linked to an increased risk of malnutrition, including overweight and obesity.

In his parents’ pharmacy in Córdoba, Argentina, Gabriel Rabinovich realised as a child that his vocation was linked to people’s health and well-being. His research into the role of galectins in the immune system, which has opened up new pathways for ...

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the ’la Caixa’ Foundation, has unveiled a new tool: the Healthy Urban Design Index (HUDI). The HUDI is a composite index that evaluates 917 European cities based on 13 ...

Regenerating skin or delivering medication to specific areas of our body is now possible thanks to the inspiration scientists draw from nature. Three projects supported by the CaixaResearch calls for Research and Innovation in Health proposals are ...

The president of the Government of Catalonia, Salvador Illa, and the chairman of the "la Caixa" Foundation and chair of the Board of Trustees of the CaixaResearch Institute, Isidro Fainé, have signed a collaboration agreement between the two ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates—only 10% after five years. One of the factors contributing to its aggressiveness is its tumor microenvironment, known as the stroma, which makes up the ...